» Articles » PMID: 33864026

On the Origin and Evolution of SARS-CoV-2

Overview
Journal Exp Mol Med
Date 2021 Apr 17
PMID 33864026
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing global outbreak of a coronavirus disease (herein referred to as COVID-19). Other viruses in the same phylogenetic group have been responsible for previous regional outbreaks, including SARS and MERS. SARS-CoV-2 has a zoonotic origin, similar to the causative viruses of these previous outbreaks. The repetitive introduction of animal viruses into human populations resulting in disease outbreaks suggests that similar future epidemics are inevitable. Therefore, understanding the molecular origin and ongoing evolution of SARS-CoV-2 will provide critical insights for preparing for and preventing future outbreaks. A key feature of SARS-CoV-2 is its propensity for genetic recombination across host species boundaries. Consequently, the genome of SARS-CoV-2 harbors signatures of multiple recombination events, likely encompassing multiple species and broad geographic regions. Other regions of the SARS-CoV-2 genome show the impact of purifying selection. The spike (S) protein of SARS-CoV-2, which enables the virus to enter host cells, exhibits signatures of both purifying selection and ancestral recombination events, leading to an effective S protein capable of infecting human and many other mammalian cells. The global spread and explosive growth of the SARS-CoV-2 population (within human hosts) has contributed additional mutational variability into this genome, increasing opportunities for future recombination.

Citing Articles

Evolutionary Mechanisms of the Emergence of the Variants of Concern of SARS-CoV-2.

Rouzine I Viruses. 2025; 17(2).

PMID: 40006952 PMC: 11861269. DOI: 10.3390/v17020197.


Multiplexed detection of respiratory virus RNA using optical pH sensors and injection-molded centrifugal microfluidics.

Suarez G, Tang Y, Bayer S, Cheung P, Nagl S Mikrochim Acta. 2025; 192(3):151.

PMID: 39937251 PMC: 11821746. DOI: 10.1007/s00604-025-06996-3.


Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling.

Nawa H, Murakami M Neuropsychopharmacol Rep. 2025; 45(1):e12520.

PMID: 39754403 PMC: 11702486. DOI: 10.1002/npr2.12520.


Immunoreactivity Analysis of MHC-I Epitopes Derived from the Nucleocapsid Protein of SARS-CoV-2 via Computation and Vaccination.

Jiang D, Ma Z, Zhang J, Sun Y, Bai T, Liu R Vaccines (Basel). 2024; 12(11).

PMID: 39591116 PMC: 11598499. DOI: 10.3390/vaccines12111214.


AltaiR: a C toolkit for alignment-free and temporal analysis of multi-FASTA data.

Silva J, Pinho A, Pratas D Gigascience. 2024; 13.

PMID: 39589438 PMC: 11590114. DOI: 10.1093/gigascience/giae086.


References
1.
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H . Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020; 581(7807):221-224. PMC: 7328981. DOI: 10.1038/s41586-020-2179-y. View

2.
Wan Y, Shang J, Graham R, Baric R, Li F . Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020; 94(7). PMC: 7081895. DOI: 10.1128/JVI.00127-20. View

3.
Kim S, Elango N, Warden C, Vigoda E, Yi S . Heterogeneous genomic molecular clocks in primates. PLoS Genet. 2006; 2(10):e163. PMC: 1592237. DOI: 10.1371/journal.pgen.0020163. View

4.
Wertheim J, Chu D, Peiris J, Kosakovsky Pond S, Poon L . A case for the ancient origin of coronaviruses. J Virol. 2013; 87(12):7039-45. PMC: 3676139. DOI: 10.1128/JVI.03273-12. View

5.
Yang Z . Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol Biol Evol. 1998; 15(5):568-73. DOI: 10.1093/oxfordjournals.molbev.a025957. View